Posted inNews and Updates
FDA Review Update: Spectral Medical’s PMX Therapy Status
Spectral Medical meets with the FDA to discuss the PMX device PMA application for treating septic shock. Get the latest update on this critical review.
Posted inNews and Updates
Biohaven Epilepsy Drug Faces FDA Clinical Hold
Biohaven’s epilepsy drug program hits a roadblock as the FDA issues a clinical hold. Learn the implications for this novel seizure treatment’s progress.
Posted inNews and Updates
New FDA Oncology Chief Outlines Future of Cancer Research
New FDA Oncology Chief Angelo de Claro vows to advance cancer research, emphasizing rapid innovation and precision medicine in his first official interview.
Posted inNews and Updates
The Real Challenges Facing Clinical Trial Enrollment
Explore the critical barriers affecting clinical trial enrollment and how patient-centric innovation is reshaping the future of oncology research.
Posted inNews and Updates
Indian Pharma Sales Surge 13%: Chronic Segment Leads Growth
Indian pharmaceutical sales reached ₹24,827 crore in August, driven by a 16% surge in chronic care. Discover the trends shaping this 13% market growth.
Posted inNews and Updates
Eyelash Extensions Linked to Eye Infections and Mites
Are your eyelash extensions causing eye health issues? Learn how poor maintenance can lead to blocked glands, mites, and severe eyelid inflammation.
Posted inNews and Updates
Eosinophilic Esophagitis Market Growth Set for 2036 Surge
Explore the future of Eosinophilic Esophagitis treatment. Discover how rising innovation and new drug pipelines are set to drive market growth through 2036.
Posted inNews and Updates
New ANCA Vasculitis Therapies: The Future of Treatment
Discover how the evolving ANCA vasculitis clinical trial pipeline is introducing targeted therapies and shifting the standard of care for patients.
Posted inNews and Updates
New mRNA Cancer Vaccine Boosts Melanoma Survival Rates
A breakthrough mRNA vaccine combined with Keytruda significantly improves survival for melanoma patients. Learn how this precision therapy works.
Posted inNews and Updates
FDA Approves CAR T-Cell Therapy Trial for Colorectal Cancer
The FDA has authorized a new clinical trial using CAR T-cell therapy to treat colorectal cancer, marking a major step forward for solid tumor research.